Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tsuboi

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Leukemia|March 5, 2004
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cellsM Kawakami, T Kimura, Y Kishimoto, et al.
Oncogene|May 12, 2015
Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalitiesN Tatsumi, N Hojo, O Yamada, et al.
Blood Cancer Journal|August 6, 2013
Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccineT Maeda, N Hosen, K Fukushima, et al.
Leukemia|November 13, 2004
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignanciesF Wu, Y Oka, A Tsuboi, et al.
JDR Clinical and Translational Research|April 13, 2019
Subjective Evaluation of Denture Adhesives: A Multicenter Randomized Controlled TrialG Ohwada, S Minakuchi, Y Sato, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Leukemia|March 5, 2004
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cellsM Kawakami, T Kimura, Y Kishimoto, et al.
Oncogene|May 12, 2015
Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalitiesN Tatsumi, N Hojo, O Yamada, et al.
Blood Cancer Journal|August 6, 2013
Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccineT Maeda, N Hosen, K Fukushima, et al.
Leukemia|November 13, 2004
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignanciesF Wu, Y Oka, A Tsuboi, et al.
JDR Clinical and Translational Research|April 13, 2019
Subjective Evaluation of Denture Adhesives: A Multicenter Randomized Controlled TrialG Ohwada, S Minakuchi, Y Sato, et al.
Pageof 11